Orlando, Lori A. http://orcid.org/0000-0003-2534-7855
Wu, R. Ryanne
Myers, Rachel A.
Neuner, Joan
McCarty, Catherine
Haller, Irina V.
Harry, Melissa
Fulda, Kimberly G.
Dimmock, David
Rakhra-Burris, Teji
Buchanan, Adam
Ginsburg, Geoffrey S.
Funding for this research was provided by:
National Human Genome Research Institute (1 U01 HG007282)
Article History
Received: 27 January 2020
Accepted: 27 October 2020
First Online: 7 November 2020
Ethics approval and consent to participate
: This study was conducted under the approval of the Duke University IRB for the overall study and under each health system’s IRBs (Duke University, Essentia Health, Medical College of Wisconsin, and University of North Texas Health Science Center) for the participants recruited at each healthcare institution. In addition, all study participants provided consent to participate through an electronic written consent.
: N/a
: The software program used in this study to perform risk assessment was developed at Duke University and has been licensed by Drs. Orlando, Wu, and Ginsburg, and Mrs. Rakhra-Burris. The purpose of licensing the software was to make it available outside of Duke University.